Riskpilot← Back to searchSign inGet full accessFinnklinikka Oy
OYActiveY-tunnus 2901841-5Saarenkärjenkatu 15-D17Medical specialists activities · NACE 8622Est. 20181 employees
Revenue 2024
EUR 307K
+18% vs 2023
EBITDA margin
7.7%
+2461% vs 2023
Equity ratio
50.0%
Financial strength
Net profit 2024
EUR 20K
+651% vs 2023
| Revenue | EUR 307K | +18% |
| EBITDA | EUR 24K | +2461% |
| Net profit | EUR 20K | +651% |
| Total assets | EUR 122K | -98% |
| Equity | EUR 61K | -99% |
| Employees | 1 | — |
Legal name
Finnklinikka Oy
Y-tunnus number
2901841-5
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
8. maaliskuuta 2018
Share capital
EUR 2 500
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimialana on yleis- ja erikoislääkärin vastaanotto, yleis- ja erikoishammaslääkärin vastaanotto, esteettiset toimenpiteet ja hoidot, koulutus ja konsultointi, yhtiön omaisuuden hoidonkannalta tarpeellinen sijoitustoiminta sekä kaikki muu laillinen liiketoiminta.
Address
Saarenkärjenkatu 15-D17
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 869 | 162 | 288 | 260 | 307 |
| Staff expenses | −282 | −141 | −138 | −152 | −153 |
| EBITDA | 161 | −110 | −21 | 1 | 24 |
| Depreciation & amort. | −0 | −0 | −4 | −4 | −3 |
| EBIT | 161 | −110 | −25 | −3 | 21 |
| Net financials | −4 | −0 | −1 | −0 | −0 |
| Profit before tax | 156 | −111 | −26 | −4 | 20 |
| Tax | 7 | −0 | −1 | −0 | −0 |
| Net profit | 150 | −111 | −25 | −4 | 20 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 176 | 8 585 | 70 | 6 399 | 122 |
| Equity | 165 | 5 408 | 49 | 4 096 | 61 |
| Long-term debt | 0 | 0 | — | 6 | 0 |
| Short-term debt | 12 | 3 176 | 22 | 2 297 | 61 |
| Total debt | 12 | 3 176 | 22 | 2 303 | 61 |
EBITDA margin
7.7%
This company
15.8%
Market median
-51% vs market
20202024
Equity ratio
50.0%
This company
38.2%
Market median
+31% vs market
20202024
Return on equity
33.1%
This company
18.4%
Market median
+80% vs market
20202024
Net profit margin
6.6%
This company
8.1%
Market median
-19% vs market
20202024
Asset turnover
2.51×
This company
1.12×
Market median
+124% vs market
20202024
Debt / equity
1.00×
This company
0.62×
Market median
-61% vs market
20202024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
DK Deputy Member | Deputy Member | 2022 |
| Former (1) | ||
VA Chief Executive Officer | Chief Executive Officer | 2018 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2018 | |
| Former (3) | ||
| Board of Directors | 2018 – 2022 | |
| Board of Directors | 2018 – 2020 | |
| Board of Directors | 2018 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Finnklinikka Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ville Anselmi Männistö | Chief Executive Officer | 0 companies |
| Dina Kusrati | Deputy Member | 0 companies |
| Jaakko Sakari Lassila | Board of Directors | 0 companies |
| Soslan Kusrati | Board of Directors | 0 companies |
| Alan Kusrati | Board of Directors | 0 companies |
| Veijo Sakari Antero Hämäläinen | Board of Directors | 0 companies |